Shalinsky, D R <br/><br/>
Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jul 1999 
 - 1905-17 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--blood<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Disease Models, Animal<br/>Drug Interactions<br/>Drug Resistance, Neoplasm<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Neovascularization, Pathologic<br/>Organic Chemicals<br/>Paclitaxel--administration & dosage<br/>Transplantation, Heterologous<br/>Treatment Outcome<br/>Tumor Cells, Cultured